-
Second intravenous immunoglobulin dose in patients with Guillain-Barré syndrome with poor prognosis (SID-GBS): a double-blind, randomised, placebo-controlled trial
Dutch GBS Study Group, 1 Apr 2021, In: Lancet neurology. 20, 4, p. 275-283 9 p.Research output: Contribution to journal › Article* › Academic › peer-review
-
Personalized extended interval dosing of natalizumab in MS: A prospective multicenter trial: A prospective multicenter trial
van Kempen, Z. L. E., Hoogervorst, E. L. J., Wattjes, M. P., Kalkers, N. F., Mostert, J. P., Lissenberg-Witte, B. I., de Vries, A., ten Brinke, A., van Oosten, B. W., Barkhof, F., Teunissen, C. E., Uitdehaag, B. M. J., Rispens, T. & Killestein, J., 11 Aug 2020, In: Neurology. 95, 6, p. e745-e754Research output: Contribution to journal › Article* › Academic › peer-review
-
Fecal Microbiota Transplantation in Neurological Disorders
Vendrik, K. E. W., Ooijevaar, R. E., de Jong, P. R. C., Laman, J. D., van Oosten, B. W., van Hilten, J. J., Ducarmon, Q. R., Keller, J. J., Kuijper, E. J. & Contarino, M. F., 24 Mar 2020, In: Frontiers in cellular and infection microbiology. 10, 98.Research output: Contribution to journal › Review article* › Academic › peer-review
- All publications
